DEXPLORER
LIVE

Serial Number

79303432

Owner

Medicare Pharmaceuticals Inc.

Attorney

LEIGH ANN LINDQUIST

Filing Date

Nov 27, 2020

Add to watchlist:

No watchlists yet
View on USPTO

DEXPLORER Trademark

Serial Number: 79303432 • Registration: 6674473

DEXPLORER is a trademark filed by Medicare Pharmaceuticals Inc. on November 27, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Medicare Pharmaceuticals Inc.

9th Fl., 443, Samnye-ro, Samnye-eup,

Entity Type: 03

Trademark Details

Filing Date

November 27, 2020

Registration Date

March 22, 2022

Published for Opposition

January 4, 2022

Goods & Services

Recorded computer software for drug development using artificial intelligence; recorded computer software for analytics for clinical trial data, for data collection, data analysis, data storing, data mining, data generation, and machine learning, all in drug discovery and drug development fields; recorded computer software for simulating drug development; recorded computer software for the analysis of data in the medical and biotechnology fields using algorithm for deep learning; recorded computer software based on artificial intelligence for image analysis and data analysis in the medical and biotechnology fields; recorded computer software for analysing medical diagnostic information; computer operating programs, recorded; recorded computer software for data processing; recorded medical software for pregnancy education; recorded medical software for uploading, storing and submitting medical images for computer-aided diagnosis of respiratory medical conditions affecting humans, providing patient diagnosis risk assessments, workflow management and billing in the field of healthcare; recorded medical software for recording, processing, transmitting, and receiving data for medical diagnostic and monitoring purposes; recorded medical software for aiding in the detection and diagnostics of congestive heart failure; recorded software for artificial intelligence conversion, analysis, processing, storage and transmission

Drug discovery services; research for medical products; scientific research and technical consulting on the test, inspection and research of medical products; development of pharmaceutical preparations and medicines; drug discovery services based on artificial intelligence; software design and development; computer software consultancy; application service provider featuring software for local, wide and global communications networks which allow users to connect remote computers and computer networks together to exchange healthcare information and data; software as a service featuring software based on artificial intelligence for the analysis of deep learning image and data in the medical and biotechnology fields; platform as a service featuring computer software platform for data collection, data analysis, data storage and data mining used in the healthcare and biotechnology fields; software as a service featuring software for data collection, data analysis, data storage and data mining used in the healthcare and biotechnology fields; design of computer software for healthcare and medical institutions; installation and maintenance of computer software for healthcare and medical institutions; technical consultation related to medical research, biotechnology data analysis and software development; technical consultation related to medical data analysis for research purposes; technical consultation related to software development in the medical field; research and development of computer software platform in the artificial intelligence field; software development for artificial intelligence service; drug discovery services through computer modeling methods; development of computer software for big data processing

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 5, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 12, 2022 FICS
FINAL DISPOSITION PROCESSED
Aug 11, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 22, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 22, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 4, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jan 4, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Jan 1, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 15, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 15, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 15, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 2, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 2, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 2, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 2, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 2, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 18, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 18, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 18, 2021 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 15, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 15, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 15, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 15, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 15, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 15, 2021 COAR
REFUSAL PROCESSED BY IB
Jun 13, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 27, 2021 RFCS
REFUSAL PROCESSED BY MPU
May 27, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 25, 2021 RFCR
NON-FINAL ACTION WRITTEN
May 24, 2021 CNRT
ASSIGNED TO EXAMINER
May 12, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 12, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 8, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 4, 2021 REPR